TRK-IN-19
TRK-IN-19 (Compound I-10) is a potent inhibitor of TRK (TRKA IC50 = 1.1 nM, TRKAG595R IC50 = 5.3 nM) . TRK-IN-19 has the potential for the research of cancer diseases[1].
Product Specifications
UNSPSC
12352005
Target
Trk Receptor
Type
Reference compound
Related Pathways
Neuronal Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/trk-in-19.html
Solubility
10 mM in DMSO
Smiles
COC1CCC(CC1)NC(C2=C3N=C(C=CN3N=C2)N(CC4=CC(F)=CC=C4)C)=O
Molecular Formula
C22H26FN5O2
Molecular Weight
411.47
References & Citations
[1]Sun M, et al. Design, synthesis and biological activity of bicyclic carboxamide derivatives as TRK inhibitors. Bioorg Med Chem. 2020 Dec 1;28 (23) :115811. doi: 10.1016/j.bmc.2020.115811.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
TrkA
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K4828605 3x 1.0 µg
Nop58 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)
Sign In for Pricing
View Details VAng-Lsx6203-50gEcoli 50 µg (E. coli)
Recombinant Campylobacter Jejuni bioB Protein (aa 1-278)
Sign In for Pricing
View Details abx376323-01 50 µg
Corepressor Interacting With RBPJ 1 (CIR) Antibody
Sign In for Pricing
View Details